Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs MERCURY LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES MERCURY LAB. VENUS REMEDIES/
MERCURY LAB.
 
P/E (TTM) x 17.7 27.9 63.3% View Chart
P/BV x 0.8 2.2 36.6% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 VENUS REMEDIES   MERCURY LAB.
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-24
MERCURY LAB.
Mar-24
VENUS REMEDIES/
MERCURY LAB.
5-Yr Chart
Click to enlarge
High Rs4301,303 33.0%   
Low Rs163535 30.4%   
Sales per share (Unadj.) Rs449.9629.7 71.4%  
Earnings per share (Unadj.) Rs21.347.1 45.2%  
Cash flow per share (Unadj.) Rs41.170.6 58.2%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs364.7423.7 86.1%  
Shares outstanding (eoy) m13.371.20 1,114.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.71.5 45.1%   
Avg P/E ratio x13.919.5 71.3%  
P/CF ratio (eoy) x7.213.0 55.4%  
Price / Book Value ratio x0.82.2 37.4%  
Dividend payout %07.4 0.0%   
Avg Mkt Cap Rs m3,9601,103 359.1%   
No. of employees `000NANA-   
Total wages/salary Rs m669142 472.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,015756 796.0%  
Other income Rs m11611 1,063.4%   
Total revenues Rs m6,130766 799.8%   
Gross profit Rs m59690 660.0%  
Depreciation Rs m26428 939.0%   
Interest Rs m14 24.5%   
Profit before tax Rs m44669 645.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m16213 1,275.9%   
Profit after tax Rs m28557 503.9%  
Gross profit margin %9.912.0 82.9%  
Effective tax rate %36.218.3 197.8%   
Net profit margin %4.77.5 63.3%  
BALANCE SHEET DATA
Current assets Rs m3,595398 902.5%   
Current liabilities Rs m794129 613.5%   
Net working cap to sales %46.635.6 130.8%  
Current ratio x4.53.1 147.1%  
Inventory Days Days281 2,164.0%  
Debtors Days Days4891,056 46.3%  
Net fixed assets Rs m2,673281 950.6%   
Share capital Rs m13412 1,113.9%   
"Free" reserves Rs m4,742496 955.3%   
Net worth Rs m4,876508 959.0%   
Long term debt Rs m38729 1,350.5%   
Total assets Rs m6,268680 922.4%  
Interest coverage x475.919.1 2,496.0%   
Debt to equity ratio x0.10.1 140.8%  
Sales to assets ratio x1.01.1 86.3%   
Return on assets %4.68.9 51.3%  
Return on equity %5.811.1 52.5%  
Return on capital %8.513.6 62.5%  
Exports to sales %024.8 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA187 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0187 0.0%   
Fx outflow Rs m03 0.0%   
Net fx Rs m0184 0.0%   
CASH FLOW
From Operations Rs m37382 453.3%  
From Investments Rs m-72-63 114.9%  
From Financial Activity Rs m-11-10 103.9%  
Net Cashflow Rs m2779 3,045.4%  

Share Holding

Indian Promoters % 41.8 73.7 56.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.2 0.0 -  
FIIs % 1.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 26.3 221.1%  
Shareholders   19,557 1,345 1,454.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VENUS REMEDIES vs MERCURY LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs MERCURY LAB. Share Price Performance

Period VENUS REMEDIES MERCURY LAB. S&P BSE HEALTHCARE
1-Day -2.62% 1.82% 1.23%
1-Month -10.44% -1.87% -0.24%
1-Year -20.70% 19.25% 43.62%
3-Year CAGR -10.73% 15.58% 20.35%
5-Year CAGR 66.32% 28.98% 26.24%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the MERCURY LAB. share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of MERCURY LAB..

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.4%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of MERCURY LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.